Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript …
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting ROCKVILLE, Md. and SUZHOU, China, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG;…
Ascentage Pharma to Report 2025 Six Month Interim Results and Provide Corporate Update on August 20, 2025 ROCKVILLE, Md. and SUZHOU, China, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX:…
Ascentage Pharma’s US Shares Climb After $126 Million IPO Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut after…
Takeda Signs Option to Market Ascentage’s Blood-Cancer Drug Takeda Pharmaceutical Co. signed an option agreement with Chinese drug developer Ascentage Pharma Group International for the development of a…